Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
anticoagulant
Pharma
FDA raises safety flags ahead of adcomm for AZ's Andexxa
As outside experts prepare to discuss AstraZeneca’s Andexxa, the FDA has flagged “major safety findings” linked to the bleeding reversal agent.
Fraiser Kansteiner
Nov 20, 2024 8:33am
Sanofi taps Minapharm for anticoagulant production in Egypt
Dec 11, 2023 10:45am
Octapharma secures FDA nod for warfarin reversal agent Balfaxar
Jul 26, 2023 3:15pm
Eliquis partners BMS, Pfizer double down on heart health
Feb 17, 2022 4:52am
Lilly, BMS drugs join top TV ad spenders in December
Jan 27, 2022 10:10am
Bristol Myers, Pfizer score another win in their Eliquis defense
Sep 7, 2021 10:54am
